| |
|
|
|
Xtalks, Online
2024-06-19
Discover an insightful webinar delving into the expanding horizons of CAR-T therapy beyond oncology.
CAR-T therapy stands at the forefront of medical innovation offering novel treatments for cancer and promising avenues for addressing a wide array of non-oncological diseases. Explore how these therapies are poised to revolutionize treatment paradigms and the adaptation of CAR-T therapy to immunomodulatory approaches for autoimmune diseases, infectious diseases, neurodegenerative disorders, cardiovascular diseases and other non-oncologic conditions.
This webinar focuses on the seamless transition of oncology expertise into non-oncological realms, illustrating how clinical development and operational insights gleaned from managing cancer treatments can be effectively applied to enhance patient care in other disease contexts. Drawing parallels between the complexities of oncology clinical development and the challenges inherent in other therapeutic areas, the expert speakers will elucidate the invaluable lessons learned and strategies devised within the field of oncology that can be leveraged to optimize outcomes in diverse medical domains.
Read more...
Register for this webinar today to gain insights into the adaptation of CAR T-cell therapy to various non-oncologic conditions.
Keywords: Drug Development, Biologics, Clinical Research, CRO, Oncology, CAR-T, CAR-T Immunotherapy, Cell Therapy, Biotherapeutics, CAR T Cells, CAR T-Cell Therapy, AAV, Allogeneic Transplantation, Cell & Gene Therapies, Stem Cell
|
|
|
|
|
|
|
|
Organized by:
|
|
Xtalks |
|
|
Invited Speakers:
|
|
Frederick Derosier, DO, Vice President, Rare Disease, Advanced Therapies, and Pediatrics, Fortrea
Dr. Brian Hamilton, MD, PhD, Senior Medical Director, Fortrea
Jan Skoumal, Executive Director, Global Project Delivery, Oncology, Fortrea
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
2024-06-19
|
|
|
|
|
|
|
|
Registration:
|
|
Free Registration
|
|
|
E-mail:
|
|
tristan@xtalks.com
|
|
|
|
|
|
|
|
|